1st Quarter - Report

AMERICAN COLLEGE OF CARDIOLOGY for AMERICAN COLLEGE OF CARDIOLOGY

Firm
Client
Income
—
Expenses
$420,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Health care quality; physician and hospital quality; health care innovation; Patient Protection and Affordable Care Act/health care reform implementation; unique device identifier policy and post-market surveillance for medical devices; clinical trial design; clinical data registries including HR 5394, Meaningful Access to Federal Health Plan Claims Data Act of 2021; HIPAA and registries; federal funding/appropriations for HHS, NIH, AHRQ, CDC, FDA, HRSA and the Childrens Hospital Graduate Medical Education payment program, the Prevention & Public Health Fund, medical research, and prevention; research and scholarly communication policy; implementation and oversight of 21st Century Cures Act; data blocking/interoperability of electronic data; health disparities; reduction/oversight of prior authorization and other administrative burdens; digital health; cardiomyopathy education and awareness; peripheral arterial disease (PAD) education and awareness; research on valvular heart disease including the CAROL Act (HR 1193/ S 1133); VA Mission Act implementation; COVID-19 and implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act, the Families First Coronavirus Response Act , the Coronavirus Aid, Relief, and Economic Security Act, Coronavirus Provider Protection Act (HR 3021), and clinician mental health including the Dr. Lorna Breen Health Care Provider Protection Act (HR 1667/S 610); patient identification; the Protecting and Transforming Cyber Health Care Act (HR 7084); the Diagnostic Device Advisory Committee Act (HR 7192); the Innovation and Competition Act S. 1260

Contacted: Food & Drug Administration (FDA); White House Office; Agency for Healthcare Research & Quality (AHRQ); SENATE; Health & Human Services, Dept of (HHS); Natl Institutes of Health (NIH); Office of Management & Budget (OMB); Centers For Medicare and Medicaid Services (CMS); HOUSE OF REPRESENTATIVES

Bills named: H.R. 1667 (117th), H.R. 1193 (117th), H.R. 3021 (117th), H.R. 7084 (117th), H.R. 5394 (117th), S. 1260 (117th), H.R. 7192 (117th)

Medicare/Medicaid MMM

Medicare physician payment; new/alternative payment models; Medicare coverage, hospital payment of cardiovascular services; access to Medicare claims data; physician and hospital quality; Quality Payment Program; clinical data registries; health care quality; medical imaging and prior authorization; the Stark Law and the in-office ancillary services exception; Medicare Access and CHIP Reauthorization Act implementation and oversight; Bipartisan Budget Act of 2015 and Medicare site of service policy; access to and supervision of Cardiac and Pulmonary Rehabilitation (HR 1956/ S 1986); graduate medical education policy including the Resident Physician Shortage Reduction Act of 2021 (HR 2256/S 834); oversight and implementation of the Protecting Access to Medicare Act of 2014, including Appropriate Use Criteria; physician-owned hospital policy; COVID-19 public health emergency and the implementation of the Coronavirus Preparedness and Response Supplemental Appropriations Act, the Families First Coronavirus Response Act, the Coronavirus Aid, Relief, and Economic Security Act; Protecting Access to Post-COVID-19 Telehealth Act (HR 366); Medicare Stability for Patients and Providers Act (HR 6048); Protecting Medicare and American Farmers from Sequester Cuts Act (S 610)

Contacted: Medicare Payment Advisory Commission (MedPAC); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; SENATE; Centers For Medicare and Medicaid Services (CMS); Office of Management & Budget (OMB)

Bills named: H.R. 366 (117th), H.R. 6048 (117th), H.R. 1956 (117th), H.R. 2256 (117th)

Tobacco TOB

Tobacco use prevention and smoking cessation; FDA regulation of tobacco; electronic cigarettes and nicotine products; tobacco and electronic cigarette policy in House and Senate Appropriations; Tobacco Tax Equity Act of 2021 (HR 2786/S 1314)

LobbyistCovered position, as disclosed
JOSEPH CODY —
JOHNATHON KRISTAN —
NOIA NICHOLAS MORSE —
LUCAS ROBERT SANDERS —
NATALIE TORENTINOS —
JAMES VAVRICEK —

Contacted: HOUSE OF REPRESENTATIVES; SENATE; Centers For Disease Control & Prevention (CDC); Food & Drug Administration (FDA)

Bills named: H.R. 2786 (117th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.